Matches in Wikidata for { <http://www.wikidata.org/entity/Q71678911> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q71678911 description "artikull shkencor i botuar më 01 shkurt 1996" @default.
- Q71678911 description "artículu científicu espublizáu en febreru de 1996" @default.
- Q71678911 description "im Februar 1996 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71678911 description "scientific article published on 01 February 1996" @default.
- Q71678911 description "wetenschappelijk artikel" @default.
- Q71678911 description "наукова стаття, опублікована в лютому 1996" @default.
- Q71678911 description "գիտական հոդված հրատարակված 1996 թվականի փետրվարի 1-ին" @default.
- Q71678911 name "Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy" @default.
- Q71678911 name "Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy" @default.
- Q71678911 name "Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy" @default.
- Q71678911 type Item @default.
- Q71678911 label "Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy" @default.
- Q71678911 label "Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy" @default.
- Q71678911 label "Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy" @default.
- Q71678911 prefLabel "Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy" @default.
- Q71678911 prefLabel "Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy" @default.
- Q71678911 prefLabel "Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy" @default.
- Q71678911 P1433 Q71678911-341EA644-9CD3-4776-B336-7F961A4891FF @default.
- Q71678911 P1476 Q71678911-A524C18B-A8E0-4C5A-82D9-F4E2D9FC80FA @default.
- Q71678911 P2093 Q71678911-16B675FD-D76F-4E62-9F20-C65B0C6D4AD9 @default.
- Q71678911 P2093 Q71678911-4DBAD0DC-7D5C-4EA0-86DE-6794D41DB9DB @default.
- Q71678911 P2093 Q71678911-786DE96C-5A6C-4D1B-A2B2-2BED583A96D9 @default.
- Q71678911 P2093 Q71678911-AF66C86F-9225-4010-A883-330A104D989E @default.
- Q71678911 P2093 Q71678911-D70DD5B5-2842-4C7E-99F5-280AF7A65B94 @default.
- Q71678911 P304 Q71678911-837B279F-ADC0-429E-9D25-62B2C858E49E @default.
- Q71678911 P31 Q71678911-2A1C546C-A296-4137-941A-1C280059EAE2 @default.
- Q71678911 P356 Q71678911-CC9F17D5-FB9A-4328-82D7-C31F8467F25F @default.
- Q71678911 P433 Q71678911-AC54A403-7A0F-4C7B-83A6-1230D079362D @default.
- Q71678911 P478 Q71678911-B1632739-4C5E-4298-9955-F17466A3A170 @default.
- Q71678911 P577 Q71678911-C1E2F563-1AE5-4BDD-B20F-01D7D1829FC0 @default.
- Q71678911 P698 Q71678911-7D8CC069-FDDC-4E09-86C0-12AD19A204CC @default.
- Q71678911 P921 Q71678911-B45005CC-E062-4990-8192-AAEF701D8A1B @default.
- Q71678911 P356 0969-8051(95)02006-3 @default.
- Q71678911 P698 8868281 @default.
- Q71678911 P1433 Q7067979 @default.
- Q71678911 P1476 "Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy" @default.
- Q71678911 P2093 "K Garmestani" @default.
- Q71678911 P2093 "L J Tiffany" @default.
- Q71678911 P2093 "O A Gansow" @default.
- Q71678911 P2093 "R W Kozak" @default.
- Q71678911 P2093 "S B Jones" @default.
- Q71678911 P304 "105-113" @default.
- Q71678911 P31 Q13442814 @default.
- Q71678911 P356 "10.1016/0969-8051(95)02006-3" @default.
- Q71678911 P433 "2" @default.
- Q71678911 P478 "23" @default.
- Q71678911 P577 "1996-02-01T00:00:00Z" @default.
- Q71678911 P698 "8868281" @default.
- Q71678911 P921 Q942 @default.